Healthcare Stocks In News: Ultragenyx (NASDAQ:RARE), Flexion (NASDAQ:FLXN), Receptos Inc (NASDAQ:RCPT), Acorda Therapeutics (NASDAQ:ACOR), Aratana Therapeutics (NASDAQ:PETX)
Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) is up over 16% today on news of the company’s initiation of phase-II trials for its lead drug candidate KRN23, which is a monoclonal antibody for X-linked Hypophosphatemia (XLH). Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) stock performance was 14.30% in last session and finished the day at $48.67. Traded volume was 435,645.00million shares in the last session and the average volume of the … Continue reading Healthcare Stocks In News: Ultragenyx (NASDAQ:RARE), Flexion (NASDAQ:FLXN), Receptos Inc (NASDAQ:RCPT), Acorda Therapeutics (NASDAQ:ACOR), Aratana Therapeutics (NASDAQ:PETX)
Healthcare Decliners: Aldeyra Therapeutics (NASDAQ:ALDX), Ignyta (NASDAQ:RXDX), Vital Therapies (NASDAQ:VTL), Actinium (NYSEMKT:ATNM), TrovaGene (NASDAQ:TROV)
Aldeyra Therapeutics Inc (NASDAQ:ALDX) quiet period is set to expire on Wednesday, June 11th. Aldeyra Therapeutics had issued 1,500,000 shares in its IPO on May 2nd, AR Network reports. The total size of the offering was $12,000,000 based on an initial share price of $8.00. Aldeyra Therapeutics Inc (NASDAQ:ALDX) stock performance was -7.08% in last session and finished the day at $6.69. Traded volume was … Continue reading Healthcare Decliners: Aldeyra Therapeutics (NASDAQ:ALDX), Ignyta (NASDAQ:RXDX), Vital Therapies (NASDAQ:VTL), Actinium (NYSEMKT:ATNM), TrovaGene (NASDAQ:TROV)
NASDAQ Insider Buying: Prospect Capital (NASDAQ:PSEC), CyrusOne (NASDAQ:CONE), National Penn Bancshares (NASDAQ:NPBC), Insys Therapeutics (NASDAQ:INSY), Bank Of The Ozarks (NASDAQ:OZRK)
Prospect Capital Corp. (NASDAQ:PSEC) CEO John F. Barry purchased 100,000 shares of the stock in a transaction dated Friday, June 13th. The stock was purchased at an average cost of $10.37 per share, for a total transaction of $1,037,000.00. Following the completion of the purchase, the chief executive officeronline.wsj.comchief executive officer now directly owns 4,110,959 shares in the company, valued at approximately $42,630,645. Prospect Capital … Continue reading NASDAQ Insider Buying: Prospect Capital (NASDAQ:PSEC), CyrusOne (NASDAQ:CONE), National Penn Bancshares (NASDAQ:NPBC), Insys Therapeutics (NASDAQ:INSY), Bank Of The Ozarks (NASDAQ:OZRK)
Stocks In News: Hewlett-Packard Company (NYSE:HPQ), Oracle Corporation (NYSE:ORCL), Cisco Systems, Inc. (NASDAQ:CSCO), International Business Machines Corp. (NYSE:IBM), Lenovo Group Limited (ADR) (OTCMKTS:LNVGY)
Hewlett-Packard Company (NYSE:HPQ) has released its own OpenStack distribution, called Helion, and, like Red Hat, plans to offer deployment and hosted services around the cloud software. Both companies are also building partner networks that will use these OpenStack distributions in products and services for specific industries or geographical areas. Hewlett-Packard Company (NYSE:HPQ) stock performance was -0.57% in last session and finished the day at $34.71. … Continue reading Stocks In News: Hewlett-Packard Company (NYSE:HPQ), Oracle Corporation (NYSE:ORCL), Cisco Systems, Inc. (NASDAQ:CSCO), International Business Machines Corp. (NYSE:IBM), Lenovo Group Limited (ADR) (OTCMKTS:LNVGY)
STock Alert: Viad Corp (NYSE:VVI), Expedia Inc (NASDAQ:EXPE), Tripadvisor Inc (NASDAQ:TRIP), Orbitz Worldwide, Inc. (NYSE:OWW), Barclays PLC (ADR) (NYSE:BCS)
Viad Corp. (NYSE:VVI) Director Albert M. Teplin sold 4,000 shares of the stock on the open market in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $23.67, for a total value of $94,680.00. Following the transaction, the director now directly owns 21,482 shares in the company, valued at approximately $508,479. Viad Corp (NYSE:VVI) stock performance was 0.74% in … Continue reading STock Alert: Viad Corp (NYSE:VVI), Expedia Inc (NASDAQ:EXPE), Tripadvisor Inc (NASDAQ:TRIP), Orbitz Worldwide, Inc. (NYSE:OWW), Barclays PLC (ADR) (NYSE:BCS)
Small Cap Decliners: Vital Therapies (NASDAQ:VTL), China Biologic Products (NASDAQ:CBPO), Versartis (NASDAQ:VSAR), Theravance (NASDAQ:TBPH), VASCO Data Security International(NASDAQ:VDSI)
Vital Therapies currently has a Zacks Rank #3 (Hold). Vital Therapies Inc (NASDAQ:VTL) stock performance was -5.83% in last session and finished the day at $30.52. Traded volume was 94.00K shares in the last session and the average volume of the stock remained 96.31K shares. China Biologic Products (CBPO) shares fell in late trading after the biopharmaceutical company said it plans to sell shares of … Continue reading Small Cap Decliners: Vital Therapies (NASDAQ:VTL), China Biologic Products (NASDAQ:CBPO), Versartis (NASDAQ:VSAR), Theravance (NASDAQ:TBPH), VASCO Data Security International(NASDAQ:VDSI)
